The Effects of Erythropoietin on Depressive Symptoms and Neurocognitive Deficits in Patients With Treatment Resistant Depression and in Patients With Remitted Bipolar Disorder - a Proof of Concept Study
Phase of Trial: Phase II
Latest Information Update: 11 Aug 2017
At a glance
- Drugs Epoetin alfa (Primary)
- Indications Bipolar depression; Bipolar disorders
- Focus Proof of concept; Therapeutic Use
- 01 Oct 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 09 Dec 2009 Actual initiation date (Sep 2009) added as reported by ClinicalTrials.gov.
- 09 Dec 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.